As p38 kinase inhibitors ω- carboxyaryl substituted diphenyl ureas
2000
(57) Abstract: The present invention is a use in the treatment of p38 mediated diseases of a group of aryl ureas, to pharmaceutical compositions for use in such therapies.
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI